Details
Stereochemistry | ACHIRAL |
Molecular Formula | C3H4N2 |
Molecular Weight | 68.0773 |
Optical Activity | NONE |
Defined Stereocenters | 0 / 0 |
E/Z Centers | 0 |
Charge | 0 |
SHOW SMILES / InChI
SMILES
N1C=CC=N1
InChI
InChIKey=WTKZEGDFNFYCGP-UHFFFAOYSA-N
InChI=1S/C3H4N2/c1-2-4-5-3-1/h1-3H,(H,4,5)
Approval Year
PubMed
Title | Date | PubMed |
---|---|---|
Stereochemical course of the biotransformation of isoprene monoepoxides and of the corresponding diols with liver microsomes from control and induced rats. | 2000 Sep |
|
Sodium salicylate increases CYP2E1 levels and enhances arachidonic acid toxicity in HepG2 cells and cultured rat hepatocytes. | 2001 Apr |
|
Discovery of 1-[3-(aminomethyl)phenyl]-N-3-fluoro-2'-(methylsulfonyl)-[1,1'-biphenyl]-4-yl]-3-(trifluoromethyl)-1H-pyrazole-5-carboxamide (DPC423), a highly potent, selective, and orally bioavailable inhibitor of blood coagulation factor Xa. | 2001 Feb 15 |
|
Selective adenosine A2A receptor antagonists. | 2001 Jan-Feb |
|
Mitochondrial targeted cytochrome P450 2E1 (P450 MT5) contains an intact N terminus and requires mitochondrial specific electron transfer proteins for activity. | 2001 Jul 6 |
|
The design and synthesis of noncovalent factor Xa inhibitors. | 2001 Jun |
|
Novel anionic annelation tactics for construction of fused heteroaromatic frameworks. 1. Synthesis of 4-substituted pyrazolo[3,4-c]quinolines, 9-substituted pyrazolo[3,4-c]quinolines, and 1,4-dihydrochromeno[4,3-c]pyrazoles. | 2001 Jun 15 |
|
Equilibria between alpha- and beta-agostic stabilized rotamers of secondary alkyl niobium complexes. | 2001 Jun 27 |
|
Novel pyrazole cannabinoids: insights into CB(1) receptor recognition and activation. | 2001 Mar |
|
Discovery of zoniporide: a potent and selective sodium-hydrogen exchanger type 1 (NHE-1) inhibitor with high aqueous solubility. | 2001 Mar 26 |
|
Tethered pyrazolyl phosphinate: pyrazolyl-N- and phosphoryl-O-metal coordination in Ph(2)P(O)[OCH(2)CH(2)(3,5-Me(2)Pz)]. | 2001 Nov 5 |
|
Solution structure investigation of Ru(II) complex ion pairs: quantitative NOE measurements and determination of average interionic distances. | 2001 Nov 7 |
|
Selective inhibition of ICAM-1 and E-selectin expression in human endothelial cells. 2. Aryl modifications of 4-(aryloxy)thieno[2,3-c]pyridines with fine-tuning at C-2 carbamides. | 2001 Oct 11 |
|
Dopamine interaction in the absence and in the presence of Cu2+ ions with macrocyclic and macrobicyclic polyamines containing pyrazole units. Crystal structures of [Cu2(L1)(H2O)2](ClO4)4 and [Cu2(H-1L3)](ClO4)3*2H2O. | 2001 Oct 31 |
|
4-(N,N-dipropylamino)benzaldehyde inhibits the oxidation of all-trans retinal to all-trans retinoic acid by ALDH1A1, but not the differentiation of HL-60 promyelocytic leukemia cells exposed to all-trans retinal. | 2002 |
|
Design, synthesis and biological activity of rigid cannabinoid CB1 receptor antagonists. | 2002 Aug |
|
3-Aryl pyrazolo[4,3-d]pyrimidine derivatives: Nonpeptide CRF-1 antagonists. | 2002 Aug 19 |
|
Syntheses and solid state structures of tris(pyrazolyl)methane complexes of sodium, potassium, calcium, and strontium: comparison of structures with analogous complexes of lead(II). | 2002 Jan 14 |
|
Spectroscopic study on charge transfer molecular complexes of pyrazole derivatives with some pi-electron acceptors. | 2002 Jul |
|
Development of a physiologically based pharmacokinetic model for methyl ethyl ketone in F344 rats. | 2002 Jul 12 |
|
A mechanistic investigation of oxidative addition of methyl iodide to [Tp*Rh(CO)(L)]. | 2002 Jun 17 |
|
Stereo- and enantioselective alkene epoxidations: a comparative study of D4- and D2-symmetric homochiral trans-dioxoruthenium(VI) porphyrins. | 2002 Jun 3 |
|
A copper(II)-pyrazole complex cation with (macro)3 imposed symmetry. | 2002 Mar |
|
New structural forms in molecular metal phosphonates: novel tri- and hexanuclear zinc(II) cages containing phosphonate and pyrazole ligands. | 2002 Mar 11 |
|
Pyrazolyl-bridged iridium dimers. 18.(1) influence of metal-metal bonding on the geometry of diiridium(II) adducts and hydrido-diiridium complexes formed from the diiridium(I) prototype [Ir(mu-pz)(PPh(3))(CO)](2) (pzH = Pyrazole) by dihydrogen addition or protonation. | 2002 Mar 25 |
|
Nickel complexes of bidentate [S2] and [SN] borato ligands. | 2002 Mar 25 |
|
Bioaffinity purification of NADP(+)-dependent dehydrogenases: studies with alcohol dehydrogenase from Thermoanaerobacter brockii. | 2002 Mar 5 |
|
Synthesis and antitumor evaluation of new polysubstituted thiazole and derived thiazolo[4, 5-d]pyrimidine systems. | 2002 May |
|
Tuning and dissecting electronic and steric effects in ammonium receptors: nonactin vs artificial receptors. | 2002 May 15 |
|
Synthesis and mechanism of action of novel pyrimidinyl pyrazole derivatives possessing antiproliferative activity. | 2002 Nov 4 |
|
Cytochrome P450 2E1 dependent catalytic activity and lipid peroxidation in rat blood lymphocytes. | 2002 Oct 11 |
|
Structure-affinity relationships of the affinity of 2-pyrazolyl adenosine analogues for the adenosine A2A receptor. | 2002 Oct 21 |
|
Synthesis and characterization of a series of (hydroperoxo)-, (alkylperoxo)-, and (mu-peroxo)palladium complexes containing the hydrotris(3,5-diisopropylpyrazolyl)borato ligand (Tp(iPr2)): (Tp(iPr2))(py)Pd-OO-X [X = H, t-Bu, Pd(Tp(iPr2))(py)] and (Tp(iPr2))(py)Pd-(mu-kappa(1):kappa(2)-OO)-PdTp(iPr2). | 2002 Oct 7 |
|
Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Management of acute ethylene glycol poisoning. | 2002 Sep |
|
Dimorphic exanthema manifested as reticular maculopapular exanthema and erythema multiforme major associated with pyrazolon derivatives. | 2002 Sep-Oct |
Patents
Name | Type | Language | ||
---|---|---|---|---|
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Code | English |
Classification Tree | Code System | Code | ||
---|---|---|---|---|
|
NCI_THESAURUS |
C29396
Created by
admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
|
Code System | Code | Type | Description | ||
---|---|---|---|---|---|
|
C45670
Created by
admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
|
PRIMARY | NCIT | ||
|
288-13-1
Created by
admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
|
PRIMARY | |||
|
14973
Created by
admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
|
PRIMARY | |||
|
m9341
Created by
admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
|
PRIMARY | Merck Index | ||
|
DB02757
Created by
admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
|
PRIMARY | |||
|
1048
Created by
admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
|
PRIMARY | |||
|
PYRAZOLE
Created by
admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
|
PRIMARY | |||
|
45410
Created by
admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
|
PRIMARY | |||
|
206-017-1
Created by
admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
|
PRIMARY | |||
|
17241
Created by
admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
|
PRIMARY | |||
|
DTXSID2059774
Created by
admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
|
PRIMARY | |||
|
C031280
Created by
admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
|
PRIMARY | |||
|
3QD5KJZ7ZJ
Created by
admin on Fri Dec 15 17:37:08 GMT 2023 , Edited by admin on Fri Dec 15 17:37:08 GMT 2023
|
PRIMARY |
SUBSTANCE RECORD